![John Borgeson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Borgeson
Financieel Directeur/CFO bij
KODIAK SCIENCES INC.
Vermogen: 8 M $ op 31-05-2026
Profiel
John Borgeson bekleedt de positie van Chief Financial Officer & Senior Vice President van Kodiak Sciences, Inc. In het verleden was de heer Borgeson Chief Financial Officer bij Solstice Biologics LLC, Vice President-Finance van Pfizer Inc. en Auditor bij Ernst & Young LLP. De heer Borgeson behaalde een MBA aan The University At Buffalo School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 211.930 ( 0,34% ) | 8 M $ | 31-05-2026 |
Actieve functies van John Borgeson
| Bedrijven | Functie | Begin |
|---|---|---|
| KODIAK SCIENCES INC. | Financieel Directeur/CFO | 01-01-2016 |
Eerdere bekende functies van John Borgeson
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01-01-2010 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | - |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Financieel Directeur/CFO | - |
Opleiding van John Borgeson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
99
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
Rochester Institute of Technology
 Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University At Buffalo School of Management
 The University At Buffalo School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
